Home / Resource Library / Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del 11q Chronic Lymphocytic Leukemia

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del 11q Chronic Lymphocytic Leukemia

Study examined long term results of ibrutinib treatment for CLL patients with 11q deletion.